AXIS Capital Declares Quarterly Dividends
AXIS Capital Declares Quarterly Dividends
AXIS Capital Holdings Limited ("AXIS Capital") (NYSE: AXS) today announced that its Board of Directors has declared a quarterly dividend of $0.44 per common share payable on October 18, 2024, to shareholders of record at the close of business on September 30, 2024.
In addition, the Board declared a dividend of $34.375 per Series E 5.50% preferred share (equivalent to $0.34375 per depositary share) payable on October 18, 2024, to shareholders of record at the close of business on September 30, 2024.
About AXIS Capital
AXIS Capital, through its operating subsidiaries, is a global specialty underwriter and provider of insurance and reinsurance solutions. The Company has shareholders’ equity of $5.7 billion at June 30, 2024, and locations in Bermuda, the United States, Europe, Singapore and Canada. Its operating subsidiaries have been assigned a financial strength rating of "A+" ("Strong") by Standard & Poor’s and "A" ("Excellent") by A.M. Best. For more information about AXIS Capital, visit our website at www.axiscapital.com.
Follow AXIS Capital on LinkedIn and X Corp.
Investor Contact
Cliff Gallant
+1 (415) 262 6843
investorrelations@axiscapital.com
Media Contact
Anna Kukowski
+1 (212) 715 3574
anna.kukowski@axiscapital.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918145674/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks